Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City

We partnered with the US Department of Health and Human Services to treat high-risk, nonadmitted coronavirus disease 2019 (COVID-19) patients with bamlanivimab in the Bronx, New York per Emergency Use Authorization criteria. Increasing posttreatment hospitalizations were observed monthly between Dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowman, Kelsie, Guo, Yi, Pirofski, Liise-anne, Wong, David, Bao, Hongkai, Chen, Victor, Hopkins, Una, Andrews, Erin, Hamel, Joseph, Keller, Marla, Bellin, Eran, Thota, Raja, Davis, Patricia, Rodriguez, Edwin Torres, Suthar, Pooja, Allen, Lauren, Rossi, James, Haviland, Adam, Orner, Erika, Szymczak, Wendy, Shujauddin, Sadahf, McCarthy, James, Binder, Barbara, Pushparaj, Vanitha, Bard, Linda, Pierino, Vincent Frank, Alsina, Leslie, Esses, David, McCaskie, Alicia, Campbell, Caron, Madzura, Tabitha, Wollowitz, Andrew, Basset, Kelly, White, Deborah, Ruiz, Rafael, Sosnowski, Frank, Nori, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391090/
https://www.ncbi.nlm.nih.gov/pubmed/34458391
http://dx.doi.org/10.1093/ofid/ofab313
_version_ 1783743189596766208
author Cowman, Kelsie
Guo, Yi
Pirofski, Liise-anne
Wong, David
Bao, Hongkai
Chen, Victor
Hopkins, Una
Andrews, Erin
Hamel, Joseph
Keller, Marla
Bellin, Eran
Thota, Raja
Davis, Patricia
Rodriguez, Edwin Torres
Suthar, Pooja
Allen, Lauren
Rossi, James
Haviland, Adam
Orner, Erika
Szymczak, Wendy
Shujauddin, Sadahf
McCarthy, James
Binder, Barbara
Pushparaj, Vanitha
Bard, Linda
Pierino, Vincent Frank
Alsina, Leslie
Esses, David
McCaskie, Alicia
Campbell, Caron
Madzura, Tabitha
Wollowitz, Andrew
Basset, Kelly
White, Deborah
Ruiz, Rafael
Sosnowski, Frank
Nori, Priya
author_facet Cowman, Kelsie
Guo, Yi
Pirofski, Liise-anne
Wong, David
Bao, Hongkai
Chen, Victor
Hopkins, Una
Andrews, Erin
Hamel, Joseph
Keller, Marla
Bellin, Eran
Thota, Raja
Davis, Patricia
Rodriguez, Edwin Torres
Suthar, Pooja
Allen, Lauren
Rossi, James
Haviland, Adam
Orner, Erika
Szymczak, Wendy
Shujauddin, Sadahf
McCarthy, James
Binder, Barbara
Pushparaj, Vanitha
Bard, Linda
Pierino, Vincent Frank
Alsina, Leslie
Esses, David
McCaskie, Alicia
Campbell, Caron
Madzura, Tabitha
Wollowitz, Andrew
Basset, Kelly
White, Deborah
Ruiz, Rafael
Sosnowski, Frank
Nori, Priya
author_sort Cowman, Kelsie
collection PubMed
description We partnered with the US Department of Health and Human Services to treat high-risk, nonadmitted coronavirus disease 2019 (COVID-19) patients with bamlanivimab in the Bronx, New York per Emergency Use Authorization criteria. Increasing posttreatment hospitalizations were observed monthly between December 2020 and March 2021 in parallel to the emergence of severe acute respiratory syndrome coronavirus 2 variants in New York City.
format Online
Article
Text
id pubmed-8391090
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-83910902021-08-27 Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City Cowman, Kelsie Guo, Yi Pirofski, Liise-anne Wong, David Bao, Hongkai Chen, Victor Hopkins, Una Andrews, Erin Hamel, Joseph Keller, Marla Bellin, Eran Thota, Raja Davis, Patricia Rodriguez, Edwin Torres Suthar, Pooja Allen, Lauren Rossi, James Haviland, Adam Orner, Erika Szymczak, Wendy Shujauddin, Sadahf McCarthy, James Binder, Barbara Pushparaj, Vanitha Bard, Linda Pierino, Vincent Frank Alsina, Leslie Esses, David McCaskie, Alicia Campbell, Caron Madzura, Tabitha Wollowitz, Andrew Basset, Kelly White, Deborah Ruiz, Rafael Sosnowski, Frank Nori, Priya Open Forum Infect Dis Brief Reports We partnered with the US Department of Health and Human Services to treat high-risk, nonadmitted coronavirus disease 2019 (COVID-19) patients with bamlanivimab in the Bronx, New York per Emergency Use Authorization criteria. Increasing posttreatment hospitalizations were observed monthly between December 2020 and March 2021 in parallel to the emergence of severe acute respiratory syndrome coronavirus 2 variants in New York City. Oxford University Press 2021-06-12 /pmc/articles/PMC8391090/ /pubmed/34458391 http://dx.doi.org/10.1093/ofid/ofab313 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Reports
Cowman, Kelsie
Guo, Yi
Pirofski, Liise-anne
Wong, David
Bao, Hongkai
Chen, Victor
Hopkins, Una
Andrews, Erin
Hamel, Joseph
Keller, Marla
Bellin, Eran
Thota, Raja
Davis, Patricia
Rodriguez, Edwin Torres
Suthar, Pooja
Allen, Lauren
Rossi, James
Haviland, Adam
Orner, Erika
Szymczak, Wendy
Shujauddin, Sadahf
McCarthy, James
Binder, Barbara
Pushparaj, Vanitha
Bard, Linda
Pierino, Vincent Frank
Alsina, Leslie
Esses, David
McCaskie, Alicia
Campbell, Caron
Madzura, Tabitha
Wollowitz, Andrew
Basset, Kelly
White, Deborah
Ruiz, Rafael
Sosnowski, Frank
Nori, Priya
Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City
title Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City
title_full Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City
title_fullStr Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City
title_full_unstemmed Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City
title_short Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City
title_sort post-severe acute respiratory syndrome coronavirus 2 monoclonal antibody treatment hospitalizations as a sentinel for emergence of viral variants in new york city
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391090/
https://www.ncbi.nlm.nih.gov/pubmed/34458391
http://dx.doi.org/10.1093/ofid/ofab313
work_keys_str_mv AT cowmankelsie postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT guoyi postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT pirofskiliiseanne postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT wongdavid postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT baohongkai postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT chenvictor postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT hopkinsuna postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT andrewserin postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT hameljoseph postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT kellermarla postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT bellineran postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT thotaraja postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT davispatricia postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT rodriguezedwintorres postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT sutharpooja postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT allenlauren postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT rossijames postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT havilandadam postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT ornererika postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT szymczakwendy postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT shujauddinsadahf postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT mccarthyjames postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT binderbarbara postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT pushparajvanitha postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT bardlinda postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT pierinovincentfrank postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT alsinaleslie postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT essesdavid postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT mccaskiealicia postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT campbellcaron postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT madzuratabitha postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT wollowitzandrew postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT bassetkelly postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT whitedeborah postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT ruizrafael postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT sosnowskifrank postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity
AT noripriya postsevereacuterespiratorysyndromecoronavirus2monoclonalantibodytreatmenthospitalizationsasasentinelforemergenceofviralvariantsinnewyorkcity

Ejemplares similares